查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1370502

卵巢癌市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Ovarian Cancer Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

抽象的

市场概况：

2022年全球卵巢癌市场规模达19亿美元。展望未来，IMARC集团预计到2028年市场规模将达到37亿美元，2023-2028年复合年增长率（CAGR）为11.56%。

卵巢癌是指由于脱氧核糖核酸（DNA）的诱变变化，卵巢中的异常细胞开始从外层组织衬里或输卵管不受控制地繁殖和生长的恶性肿瘤。目前，可以在多种诊断和药物的支持下进行治疗，包括抗风湿药物、抗肿瘤药物以及PARP、有丝分裂和VEGF/VEGFR抑制剂。除此之外，卵巢癌的治疗还包括手术、化疗、荷尔蒙、放射和标靶治疗，这些治疗有助于杀死癌细胞，从而缓解征兆和系统症状。这些疗法是由医生在确定多种因素后执行的，例如肿瘤的扩散、个人的整体健康状况以及卵巢癌的大小和类型。

卵巢癌市场趋势：

由于乳癌基因 1 (BRCA1) 或 BRCA2 的基因突变，上皮癌、间质癌和生殖细胞卵巢癌的盛行率不断增加，特别是在女性老年族群中，这主要推动了市场的成长。与此一致的是，对贝伐单抗（Avastin）和帕唑帕尼（Votrient）等有效治疗药物的需求不断增长，成为另一个生长诱导因素。此外，医疗保健领域广泛采用联合疗法来防止抗药性和提高治疗效果，这也支持了市场的成长。此外，品牌药物的专利持续到期促使政府和製药公司推出新型重组药物，这反过来又推动了市场成长。此外，非政府组织 (NGO) 为提高消费者对早期卵巢癌诊断的症状、治疗和益处的认识而采取的广泛倡议正在推动市场成长。除此之外，主要参与者之间的策略合作以及持续的研发（R＆D）活动以产生有效的治疗干预措施，正在为市场创造积极的前景。

本报告回答的关键问题：

  • 迄今为止，全球卵巢癌市场表现如何，未来几年将如何表现？
  • COVID-19 对全球卵巢癌市场有何影响？
  • 主要区域市场有哪些？
  • 依类型划分市场是怎么样的？
  • 根据治疗类型的市场划分是怎样的？
  • 基于最终用户的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球卵巢癌市场的结构如何？谁是主要参与者？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球卵巢癌市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按类型分類的市场细分

  • 上皮性卵巢癌
    • 市场走向
    • 市场预测
  • 生殖细胞卵巢癌
    • 市场走向
    • 市场预测
  • 基质细胞卵巢癌
    • 市场走向
    • 市场预测

第 7 章：按治疗类型分類的市场区隔

  • 免疫疗法
    • 市场走向
    • 市场预测
  • 化疗
    • 市场走向
    • 市场预测
  • 标靶治疗
    • 市场走向
    • 市场预测
  • 手术
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：最终用户的市场区隔

  • 医院
    • 市场走向
    • 市场预测
  • 居家护理
    • 市场走向
    • 市场预测
  • 专科中心
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AbbVie Inc.
    • Amneal Pharmaceuticals Inc.
    • AstraZeneca plc
    • Eli Lilly and Company
    • F. Hoffmann-La Roche AG
    • GSK plc
    • Hikma Pharmaceuticals PLC
    • Lupin Limited
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112023A6407

Abstract

Market Overview:

The global ovarian cancer market size reached US$ 1.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2028, exhibiting a growth rate (CAGR) of 11.56% during 2023-2028.

Ovarian cancer refers to a malignant tumor wherein abnormal cells in the ovary begin to multiply and grow uncontrollably from the outer tissue lining or fallopian tubes due to mutagenic changes in the deoxyribonucleic acid (DNA). At present, it can be treated with the support of various diagnoses and drugs, including antirheumatics, antineoplastics, and PARP, mitotic, and VEGF/VEGFR inhibitors. Apart from this, ovarian cancer treatment involves surgery, chemotherapy, hormone, radiation, and targeted therapies that help kill cancer cells to provide relief from signs and systems. These therapeutics are executed by medical practitioners after determining multiple factors, such as the spread of the tumor, individuals' general health, and the size and type of ovarian cancer.

Ovarian Cancer Market Trends:

The increasing prevalence of epithelial, stromal, and germ cell ovarian cancer, especially amongst the female geriatric population, due to the genetic mutation of breast cancer gene 1 (BRCA1) or BRCA2, is primarily driving the market growth. In line with this, the rising need for effective therapeutic drugs, such as bevacizumab (Avastin) and pazopanib (Votrient), is acting as another growth-inducing factor. Additionally, the widespread adoption of combination therapies in the healthcare sector to prevent drug resistance and increase treatment efficacy is supporting the market growth. Moreover, the ongoing patent expiration of branded medications has prompted governments and pharmaceutical companies to launch novel recombinant drugs, which, in turn, is propelling market growth. Furthermore, extensive initiatives undertaken by non-governmental organizations (NGOs) to sensitize consumers regarding the symptoms, treatments, and benefits of early ovarian cancer diagnosis are impelling the market growth. Apart from this, strategic collaborations amongst key players and continuous research and development (R&D) activities to produce efficient therapeutic interventions are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global ovarian cancer market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, treatment type and end user.

Breakup by Type:

Epithelial Ovarian Cancer

Germ Cell Ovarian Cancer

Stromal Cell Ovarian Cancer

Breakup by Treatment Type:

Immunotherapy

Chemotherapy

Targeted Therapy

Surgery

Others

Breakup by End User:

Hospitals

Homecare

Speciality Centre

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amneal Pharmaceuticals Inc., AstraZeneca plc, Eli Lilly and Company, F. Hoffmann-La Roche AG, GSK plc, Hikma Pharmaceuticals PLC, Lupin Limited, Pfizer Inc. and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report:

  • How has the global ovarian cancer market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global ovarian cancer market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global ovarian cancer market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Ovarian Cancer Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Epithelial Ovarian Cancer
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Germ Cell Ovarian Cancer
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Stromal Cell Ovarian Cancer
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Immunotherapy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chemotherapy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Targeted Therapy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Surgery
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Homecare
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Speciality Centre
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AbbVie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amneal Pharmaceuticals Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 AstraZeneca plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Eli Lilly and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 F. Hoffmann-La Roche AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 GSK plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Hikma Pharmaceuticals PLC
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Lupin Limited
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pfizer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Teva Pharmaceutical Industries Ltd.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Ovarian Cancer Market: Major Drivers and Challenges
  • Figure 2: Global: Ovarian Cancer Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Ovarian Cancer Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Ovarian Cancer Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Ovarian Cancer Market: Breakup by Treatment Type (in %), 2022
  • Figure 6: Global: Ovarian Cancer Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Ovarian Cancer Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Ovarian Cancer (Epithelial Ovarian Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Ovarian Cancer (Epithelial Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Ovarian Cancer (Germ Cell Ovarian Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Ovarian Cancer (Germ Cell Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Ovarian Cancer (Stromal Cell Ovarian Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Ovarian Cancer (Stromal Cell Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Ovarian Cancer (Immunotherapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Ovarian Cancer (Immunotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Ovarian Cancer (Chemotherapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Ovarian Cancer (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Ovarian Cancer (Targeted Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Ovarian Cancer (Targeted Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Ovarian Cancer (Surgery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Ovarian Cancer (Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Ovarian Cancer (Other Treatment Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Ovarian Cancer (Other Treatment Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Ovarian Cancer (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Ovarian Cancer (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Ovarian Cancer (Homecare) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Ovarian Cancer (Homecare) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Ovarian Cancer (Speciality Centre) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Ovarian Cancer (Speciality Centre) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Ovarian Cancer (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Ovarian Cancer (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: North America: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: North America: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: United States: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: United States: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Canada: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Canada: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Asia-Pacific: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Asia-Pacific: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: China: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: China: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Japan: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Japan: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: India: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: India: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: South Korea: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: South Korea: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Australia: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Australia: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Indonesia: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Indonesia: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Others: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Others: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Europe: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Europe: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Germany: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Germany: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: France: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: France: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: United Kingdom: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: United Kingdom: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Italy: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Italy: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Spain: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Spain: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Russia: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Russia: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Latin America: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Latin America: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Brazil: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Brazil: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Mexico: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Mexico: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Middle East and Africa: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Middle East and Africa: Ovarian Cancer Market: Breakup by Country (in %), 2022
  • Figure 80: Middle East and Africa: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Global: Ovarian Cancer Industry: SWOT Analysis
  • Figure 82: Global: Ovarian Cancer Industry: Value Chain Analysis
  • Figure 83: Global: Ovarian Cancer Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Ovarian Cancer Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Ovarian Cancer Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Ovarian Cancer Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
  • Table 4: Global: Ovarian Cancer Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Ovarian Cancer Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Ovarian Cancer Market: Competitive Structure
  • Table 7: Global: Ovarian Cancer Market: Key Players